Galectin Therapeutics jobs and careers

Norcross, GA, United States

galectintherapeutics.com LinkedIn @GalectinGALT

About Galectin Therapeutics

Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.

Founded in 2000 by Anatole Klyosov and James Czirr.

Pharmaceutical Biopharma Biotechnology Health Care

Founded: 2000
Employees: 11 to 50
Total funding: $108.5M
Headquarters: Norcross

Leadership

The top of Galectin Therapeutics's org chart, with how many people report into each leader.

JL

Joel Lewis

CEO & President

10 reports

MM

Marla Mills-Wilson

Executive Director, Clinical Operations

3 reports

KJ

Khurram Jamil

Chief Medical Officer

2 reports

JC

Jack W. Callicutt

CFO

1 report

BK

Beth Knowles

Executive Assistant & Office Manager

Board

GA

Gilbert F. Amelio

Independent Director

RU

Richard E. Uihlein

Chairman

ES

Elissa J. Schwartz

Independent Director

MR

Marc Rubin

Independent Director

GO

Gilbert S. Omenn

Independent Director

JC

James C. Czirr

Director

Jobs at Galectin Therapeutics

No open positions right now. Explore more companies on TheJobsMap.